FDA rejects Chinese cancer drugs
The United States Food and Drug Administration (FDA) on Monday declined to approve two proposed new cancer drugs that were developed in China. One of the two companies, Hutchmed — which is controlled by Hong Kong tycoon Li Ka-shing (李嘉誠 Lǐ Jiāchéng) — said the FDA sent a letter denying approval of its new drug used to…